Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00755820 · ClinicalTrials.gov registry record
Food Exposure Therapy in Anorexia Nervosa
A clinical trial of Anorexia Nervosa, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- 32
- Enrollment target
- 1
- Study location
NCT00755820: Completed study of Anorexia Nervosa, sponsored by New York State Psychiatric Institute.
NCT00755820 is a study of Anorexia Nervosa that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 32 participants, below the 949-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00755820, a study of Anorexia Nervosa, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a research study to determine whether a medication called D-cycloserine (DCS) in combination with a type of psychotherapy called Exposure Therapy is helpful to patients with anorexia nervosa.
Conditions Studied
Interventions
- BEHAVIORAL Supportive Psychotherapy
- BEHAVIORAL Exposure Therapy + D-Cycloserine
- BEHAVIORAL Exposure Therapy + Placebo
Study Locations (1)
New York
- New York State Psychiatric Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2008-01 |
| Est. Completion | 2012-01 |
What the finished NCT00755820 record still lists
NCT00755820 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 949-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Anorexia Nervosa appearing as the primary indexed condition, and to 3 interventions - of which Supportive Psychotherapy is the first listed.
NCT00755820 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00755820 about?
NCT00755820 is a clinical study titled "Food Exposure Therapy in Anorexia Nervosa". This is a research study to determine whether a medication called D-cycloserine (DCS) in combination with a type of psychotherapy called Exposure Therapy is helpful to patients with anorexia nervosa.
What is the current status of trial NCT00755820?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2008-01. Estimated completion is 2012-01.
What conditions does trial NCT00755820 study?
This clinical trial studies the following conditions: Anorexia Nervosa.
What interventions are being tested in trial NCT00755820?
The interventions under investigation include: Supportive Psychotherapy (BEHAVIORAL), Exposure Therapy + D-Cycloserine (BEHAVIORAL), Exposure Therapy + Placebo (BEHAVIORAL).
Who is sponsoring clinical trial NCT00755820?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00755820 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anorexia Nervosa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00755820's enrollment target sits among peer trials
32 28th of 43 higher than 15 of 43 other Anorexia Nervosa trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anorexia Nervosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Diet for Relapse Prevention in Anorexia Nervosa
RECRUITING · NA
-
Facing Eating Disorder Fears for Anorexia Nervosa
RECRUITING · NA
-
Therapeutic Ketogenic Diet in Anorexia Nervosa
RECRUITING · NA
-
Confirming the Effectiveness of Online Guided Self-Help Family-Based Treatment for Adolescent Anorexia Nervosa
RECRUITING · NA
-
Eating Disorders Genetics Initiative 2
RECRUITING
-
Incentive Processing and Learning in Anorexia Nervosa and Bulimia Nervosa
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia